PRESS RELEASE
June 2008
Eurofins Forensic Services successfully gains inclusion in the National Framework Agreement
Eurofins Forensic Services (EFS) is pleased to announce its successful inclusion into the national framework agreement for Forensic Analysis Services.
As part of the national framework agreement EFS will offer police forces the opportunity to save time and expense for the analysis of DNA– PACE, Crime Scene Stains and Toxicology testing. In addition, Eurofins Forensic Services is able to provide the UK police forces with enhanced analytical services, through a growing network of specialist forensic DNA and Toxicology laboratories capitalising on existing activities in continental Europe.
Paul Hackett, Director of Eurofins Forensic Services said: “This latest development is extremely encouraging as it shows a willingness of the police to open up the market, promoting competition and better value for money services”.
Notes for the editor:
Eurofins Forensic Services – Specialist Analysis
Eurofins Forensic Services specialises in the provision of forensic DNA and toxicological testing and support services to police, legal, and criminal justice organisations within the UK.
Eurofins – a global leader in bio-analysis
Eurofins Scientific, a life sciences company operating internationally to provide a comprehensive range of analytical testing services to clients from a variety of industries including the pharmaceutical, food and environmental sectors.
With over 7,000 staff in more than 100 laboratories across 29 countries, Eurofins offers a portfolio of over 25,000 reliable analytical methods for evaluating the authenticity, origin, safety, identity, composition and purity of biological substances and products. The Group is committed to provide its customers with high quality services, accurate results in time and, if requested, expert advice by our highly qualified staff.
The Eurofins Group is one of the global market leaders in this field of applied life sciences. It intends to pursue its dynamic growth strategy and expand both its technology portfolio and its geographic reach. Through R&D, in-licensing and acquisitions, the Group draws on the latest developments in the field of biotechnology to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
As one of the most innovative and quality oriented international player in its industry, Eurofins is ideally positioned to support its clients’ increasingly stringent quality and safety standards and the demands of regulatory authorities around the world.
